Clinical Trial Update: Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for APSMNF in male androgenetic alopecia, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• APSMNF

Snippet

Sponsor: Apsen Farmaceutica S.A. | Conditions: Alopecia, Androgenetic | Phase 3 | Status: NOT_YET_RECRUITING